CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background
Jeremy S. Lum(University of Wollongong), Justin J. Yerbury(University of Wollongong), Luke McAlary(University of Wollongong), Christen G. Chisholm(University of Wollongong), Fabian Kreilaus(Camden and Campbelltown Hospitals), Josh Snow(University of Wollongong), Mikayla Brown(University of Wollongong), Diane Ly(University of Wollongong), Lachlan E. McInnes(The University of Melbourne), Kara L. Vine(University of Wollongong), Tim Karl(Western Sydney University), Natalie E. Farrawell(University of Wollongong), Peter J. Crouch(The University of Melbourne), Paul S. Donnelly(The University of Melbourne), Sara Nikseresht(Box Hill Hospital)
Cited by 21
Related Papers
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
|Journal of Controlled Release|2018|297
Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
|Scientific Reports|2016|281
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
|Anti-Cancer Agents in Medicinal Chemistry|2009|269
Walking the tightrope: proteostasis and neurodegenerative disease
|Journal of Neurochemistry|2016|238
Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
|Advanced Materials|2018|217